ALLMedicine™ Hepatitis C Virus Center

Jun 14th, 2021 - While Opioid use disorder (OUD)-related mortality is epidemic in the United States, regions like Appalachia are disproportionately affected. Moreover, a dual epidemic of Hepatitis C virus (HCV) infections and OUD-related admissions has been observ...

Jun 14th, 2021 - In 2019 the United States Preventive Services Task Force (USPSTF) released draft guidelines recommending universal hepatitis C virus (HCV) screening for individuals aged 18-79. We aimed to assess the efficacy of an emergency department-based HCV s...

Jun 12th, 2021 - People who inject drugs (PWID) have a high prevalence of hepatitis C virus (HCV). Group treatment is a practical option for addressing barriers to treatment in this population. Prior research on group treatment has resulted in mixed conclusions ab...

Jun 12th, 2021 - The Affordable Care Act (ACA) expanded Medicaid around the same time that direct-acting antivirals (DAAs) became widely available for the treatment of hepatitis C virus (HCV). However, there is significant variation in Medicaid HCV treatment eligi...

Jun 11th, 2021 - We assessed the performance characteristics of the Fibrosis-4 (FIB-4) score in a veteran population with chronic hepatitis C virus (HCV) infection and used vibration controlled transient elastography (VCTE) as the gold standard.All VCTE studies we...

Sep 21st, 2020 - Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with approximately 71 million chronically infected individuals worldwide. Clinical care for patients with HCV-related liver disease has advanced considerably thanks to an...

Mar 2nd, 2020 - Hepatitis C virus (HCV) is the most common chronic blood-borne pathogen in the US and a leading cause of complications from chronic liver disease. HCV is associated with more deaths than the top 60 other reportable infectious diseases combined, in...

Sep 23rd, 2019 - Description: The Kidney Disease: Improving Global Outcomes (KDIGO) 2018 clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C virus (HCV) infection in chronic kidney disease (CKD) is an extensive updat...

Sep 23rd, 2019 - This article has been corrected. The original version (PDF) is appended to this article as a Supplement. The Kidney Disease: Improving Global Outcomes (KDIGO) 2018 clinical practice guideline for the prevention, diagnosis, evaluation, and treatmen...

Aug 27th, 2019 - The Food and Drug Administration (FDA) has received reports that the use of Mavyret, Zepatier, or Vosevi to treat chronic hepatitis C in patients with moderate to severe liver impairment has resulted in rare cases of worsening liver function or li...

Jun 14th, 2021 - While Opioid use disorder (OUD)-related mortality is epidemic in the United States, regions like Appalachia are disproportionately affected. Moreover, a dual epidemic of Hepatitis C virus (HCV) infections and OUD-related admissions has been observ...

Jun 14th, 2021 - In 2019 the United States Preventive Services Task Force (USPSTF) released draft guidelines recommending universal hepatitis C virus (HCV) screening for individuals aged 18-79. We aimed to assess the efficacy of an emergency department-based HCV s...

Jun 12th, 2021 - People who inject drugs (PWID) have a high prevalence of hepatitis C virus (HCV). Group treatment is a practical option for addressing barriers to treatment in this population. Prior research on group treatment has resulted in mixed conclusions ab...

Jun 12th, 2021 - The Affordable Care Act (ACA) expanded Medicaid around the same time that direct-acting antivirals (DAAs) became widely available for the treatment of hepatitis C virus (HCV). However, there is significant variation in Medicaid HCV treatment eligi...

Jun 11th, 2021 - We assessed the performance characteristics of the Fibrosis-4 (FIB-4) score in a veteran population with chronic hepatitis C virus (HCV) infection and used vibration controlled transient elastography (VCTE) as the gold standard.All VCTE studies we...

Jun 3rd, 2021 - Hepatitis C is a liver disease caused by the hepatitis C virus (HCV). It is a major public health problem. Infection with HCV can lead to both acute and chronic hepatitis, varying in severity from a mild illness of short duration to a serious, lif...

May 27th, 2021 - While liver transplant outcomes were historically poor in people coinfected with HIV and hepatitis C virus (HCV), they have improved significantly in the era of direct-acting antiviral (DAA) therapy, a recent analysis of U.S. organ transplant data...

May 18th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The COVID-19 pandemic has coincided with sharp declines in routine testing for and treatment of hepatitis C virus (HCV) infection, according to th...

May 2nd, 2021 - (Reuters) - Combining Gilead Sciences' antiviral drug remdesivir - the current standard of care for hospitalized COVID-19 patients - with oral drugs used to treat hepatitis C virus (HCV) might be more effective than remdesivir alone, laboratory ex...

Apr 28th, 2021 - NEW YORK (Reuters Health) - A combination of ravidasvir and sofosbuvir appears to be an effective treatment for chronic hepatitis C virus (HCV) infection across a diverse pool of patients who took part in the first half of the single-arm STORM-C-1...